NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
Labor CAIO Outlines Responsible and Ethical AI Priorities, Use Cases
Department of Labor Chief AI Officer Mangala Kuppa outlined how her role is shaping the agency’s artificial intelligence strategy.
20m watch -
Storytelling Miniseries: Mastering Mindful Communication with Elizabeth Barry
Join us as Elizabeth shares her unique approach to communication, offering tips and strategies for personal growth and leadership through storytelling.
17m listen -
VA Rolls Out Ride-Share Program With Uber
Veterans Health Administration Chief of Innovation Indra Sandal and Veterans Transportation Program Director Benjamin Williams discuss the program’s journey from pilot to live program.
26m listen -
Census Bureau Embraces Modernization, Data Innovation
Census Deputy Director and Chief Operating Officer Ron Jarmin outlines how the bureau is expanding its data collection, using AI to make Census staff more efficient and spearheading modernization efforts to better meet 21st century data needs.
23m listen
